Phosphate steering by Flap Endonuclease 1 promotes 5´-flap specificity and incision to prevent genome instability

DNA replication and repair enzyme Flap Endonuclease 1 (FEN1) is vital for genome integrity, and FEN1 mutations arise in multiple cancers. FEN1 precisely cleaves single-stranded (ss) 50-flaps one nucleotide into duplex (ds) DNA. Yet, how FEN1 selects for but does not incise the ss 50-flap was enigmatic. Here we combine crystallographic, biochemical and genetic analyses to show that two dsDNA binding sites set the 50polarity and to reveal unexpected control of the DNA phosphodiester backbone by electrostatic interactions. Via ‘phosphate steering’, basic residues energetically steer an inverted ss 50-flap through a gateway over FEN1’s active site and shift dsDNA for catalysis. Mutations of these residues cause an 18,000-fold reduction in catalytic rate in vitro and large-scale trinucleotide (GAA)n repeat expansions in vivo, implying failed phosphate-steering promotes an unanticipated lagging-strand template-switch mechanism during replication. Thus, phosphate steering is an unappreciated FEN1 function that enforces 50-flap specificity and catalysis, preventing genomic instability

Phosphate steering by Flap Endonuclease 1 promotes 5´-flap specificity and incision to prevent genome instability

DNA replication and repair enzyme Flap Endonuclease 1 (FEN1) is vital for genome integrity, and FEN1 mutations arise in multiple cancers. FEN1 precisely cleaves single-stranded (ss) 50-flaps one nucleotide into duplex (ds) DNA. Yet, how FEN1 selects for but does not incise the ss 50-flap was enigmatic. Here we combine crystallographic, biochemical and genetic analyses to show that two dsDNA binding sites set the 50polarity and to reveal unexpected control of the DNA phosphodiester backbone by electrostatic interactions. Via ‘phosphate steering’, basic residues energetically steer an inverted ss 50-flap through a gateway over FEN1’s active site and shift dsDNA for catalysis. Mutations of these residues cause an 18,000-fold reduction in catalytic rate in vitro and large-scale trinucleotide (GAA)n repeat expansions in vivo, implying failed phosphate-steering promotes an unanticipated lagging-strand template-switch mechanism during replication. Thus, phosphate steering is an unappreciated FEN1 function that enforces 50-flap specificity and catalysis, preventing genomic instability

USP30 sets a trigger threshold for PINK1–PARKIN amplification of mitochondrial ubiquitylation

The mitochondrial deubiquitylase USP30 negatively regulates the selective autophagy of damaged mitochondria. We present the characterisation of an N-cyano pyrrolidine compound, FT3967385, with high selectivity for USP30. We demonstrate that ubiquitylation of TOM20, a component of the outer mitochondrial membrane import machinery, represents a robust biomarker for both USP30 loss and inhibition. A proteomics analysis, on a SHSY5Y neuroblastoma cell line model, directly compares the effects of genetic loss of USP30 with chemical inhibition. We have thereby identified a subset of ubiquitylation events consequent to mitochondrial depolarisation that are USP30 sensitive. Within responsive elements of the ubiquitylome, several components of the outer mitochondrial membrane transport (TOM) complex are prominent. Thus, our data support a model whereby USP30 can regulate the availability of ubiquitin at the specific site of mitochondrial PINK1 accumulation following membrane depolarisation. USP30 deubiquitylation of TOM complex components dampens the trigger for the Parkin-dependent amplification of mitochondrial ubiquitylation leading to mitophagy. Accordingly, PINK1 generation of phospho-Ser65 ubiquitin proceeds more rapidly in cells either lacking USP30 or subject to USP30 inhibition

Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction on Vascular End-points in Chronic Kidney Disease (IMPROVE-CKD) study

Introduction: Patients with chronic kidney disease (CKD) are at heightened cardiovascular risk, which has been associated with abnormalities of bone and mineral metabolism. A deeper understanding of these abnormalities should facilitate improved treatment strategies and patient-level outcomes, but at present there are few large, randomised controlled clinical trials to guide management. Positive associations between serum phosphate and fibroblast growth factor 23 (FGF-23) and cardiovascular morbidity and mortality in both the general and CKD populations have resulted in clinical guidelines suggesting that serum phosphate be targeted towards the normal range, although few randomised and placebo-controlled studies have addressed clinical outcomes using interventions to improve phosphate control. Early preventive measures to reduce the development and progression of vascular calcification, left ventricular hypertrophy and arterial stiffness are crucial in patients with CKD. Methods and analysis: We outline the rationale and protocol for an international, multicentre, randomised parallel-group trial assessing the impact of the non-calcium-based phosphate binder, lanthanum carbonate, compared with placebo on surrogate markers of cardiovascular disease in a predialysis CKD population—the IM pact of P hosphate R eduction O n V ascular E nd-points (IMPROVE)-CKD study. The primary objective of the IMPROVE-CKD study is to determine if the use of lanthanum carbonate reduces the burden of cardiovascular disease in patients with CKD stages 3b and 4 when compared with placebo. The primary end-point of the study is change in arterial compliance measured by pulse wave velocity over a 96-week period. Secondary outcomes include change in aortic calcification and biochemical parameters of serum phosphate, parathyroid hormone and FGF-23 levels. Ethics and dissemination: Ethical approval for the IMPROVE-CKD trial was obtained by each local Institutional Ethics Committee for all 17 participating sites in Australia, New Zealand and Malaysia prior to study commencement. Results of this clinical trial will be published in peer-reviewed journals and presented at conferences.Nicole Lioufas, Nigel D Toussaint, Eugenia Pedagogos, Grahame Elder, Sunil V Badve, Elaine Pascoe, Andrea Valks, Carmel Hawley, Geoffrey A Block, Neil C Boudville, Katrina Campbell, James D Cameron, Sylvia S M Chen, Randall J Faull, Stephen G Holt, Lai S Hooi, Dana Jackson, Meg J Jardine, David W Johnson, Peter G Kerr, Kenneth K Lau, Alicia Morrish, Vlado Perkovic, Kevan R Polkinghorne, Carol A Pollock, Donna Reidlinger, Laura Robison, Edward R Smith, Robert J Walker, Angela Yee Moon Wang

Understanding management gurus and historical narratives: The benefits of a historic turn in management and organization studies

A historic turn in organization studies requires a basic theoretical understanding of ‘doing history’ and an appreciation of the centrality of narrative in history. Following the cultural turn in history, narrativist historians and philosophers of history such as Hayden White, Frank Ankersmit and Paul Ricoeur have made the case that narrative is an essential and unavoidable component in history. We demonstrate the persuasive capacity of narrative through a narrativist critique of three best-selling ‘management gurus’. This analysis illustrates the following: (1) the narrative features of popular organizational theories; (2) the basis of the success of guru literature; and (3) why gurus and organizational scientists themselves do not understand the narratological mechanisms behind their success. Finally, we maintain that historical narrativism offers the possibility for positioning organizational history as a highly relevant field for management academics, gurus and even managers, providing support for a historic turn

Whole-genome sequencing reveals host factors underlying critical COVID-19

Critical COVID-19 is caused by immune-mediated inflammatory lung injury. Host genetic variation influences the development of illness requiring critical care1 or hospitalization2,3,4 after infection with SARS-CoV-2. The GenOMICC (Genetics of Mortality in Critical Care) study enables the comparison of genomes from individuals who are critically ill with those of population controls to find underlying disease mechanisms. Here we use whole-genome sequencing in 7,491 critically ill individuals compared with 48,400 controls to discover and replicate 23 independent variants that significantly predispose to critical COVID-19. We identify 16 new independent associations, including variants within genes that are involved in interferon signalling (IL10RB and PLSCR1), leucocyte differentiation (BCL11A) and blood-type antigen secretor status (FUT2). Using transcriptome-wide association and colocalization to infer the effect of gene expression on disease severity, we find evidence that implicates multiple genes—including reduced expression of a membrane flippase (ATP11A), and increased expression of a mucin (MUC1)—in critical disease. Mendelian randomization provides evidence in support of causal roles for myeloid cell adhesion molecules (SELE, ICAM5 and CD209) and the coagulation factor F8, all of which are potentially druggable targets. Our results are broadly consistent with a multi-component model of COVID-19 pathophysiology, in which at least two distinct mechanisms can predispose to life-threatening disease: failure to control viral replication; or an enhanced tendency towards pulmonary inflammation and intravascular coagulation. We show that comparison between cases of critical illness and population controls is highly efficient for the detection of therapeutically relevant mechanisms of disease

Metal matrix encapsulation of waste

The ultimate disposition of nuclear wastes is frequently mentioned by opponents of nuclear power as an unresolved issue, and it is true that adequate demonstrations of nuclear waste disposal have not been performed. It has been suggested, however, that technology is either available or readily amenable for full-scale radioactive demonstrations once necessary Federal policy and criteria decisions are made. Public acceptance of nuclear power would be enhanced if the uncertainty of nuclear waste disposal is dispelled by successful waste disposal demonstrations under the full scrutiny of the public. It is our opinion that only full-scale radioactive demonstrations of waste disposal would qualify as an adequate demonstration and thereby reduce the antagonism which retards development of nuclear power. Thus, now is the time to initiate such demonstrations and we suggest that the concept of metal encapsulation of solidified high level waste forms be used as the method that can be acceptable to both the public and industry. This paper will briefly introduce the metal encapsulation concept by presenting a process flow sheet for encapsulation of wastes that would be produced by a 5 Mg/day reprocessing plant. Some probable attributes of metal-encapsulated waste forms and glass monoliths and of the fabrication processes for these waste forms will be discussed in order to illustrate the bases for the recommendation that metal encapsulation be the preferred route to achieving successful early demonstrations of nuclear waste disposal

Review of metal-matrix encapsulation of solidified radioactive high-level waste

Literature describing previous and current work on the encapsulation of solidified high-level waste forms in a metal matrix was reviewed. Encapsulation of either stabilized calcine pellets or glass beads in alloys by casting techniques was concluded to be the most developed and direct approach to fabricating solid metal-matrix waste forms. Further characterizations of the physical and chemical properties of metal-matrix waste forms are still needed to assess the net attributes of metal-encapsulation alternatives. Steady-state heat transfer properties of waste canisters in air and water environments were calculated for four reference waste forms: (1) calcine, (2) glass monoliths, (3) metal-encapsulated calcine, and (4) metal-encapsulated glass beads. A set of criteria for the maximum allowable canister centerline and surface temperatures and heat generation rates per canister at the time of shipment to a Federal repository was assumed, and comparisons were made between canisters of these reference waste forms of the shortest time after reactor discharge that canisters could be filled and the subsequent ''interim'' storage times prior to shipment to a Federal repository for various canister diameters and waste ages. A reference conceptual flowsheet based on existing or developing technology for encapsulation of stabilized calcine pellets is discussed. Conclusions and recommendations are presented

Hydration process of nuclear-waste glass: an interim report

Aging of simulated nuclear waste glass by contact with a controlled-temperature, humid atmosphere results in the formation of a double hydration layer penetrating the glass, as well as the formation of minerals on the glass surface. The hydration process can be described by Arrhenius behavior between 120 and 240/sup 0/C. Results suggest that simulated aging reactions are necessary for demonstrating that nuclear waste forms can meet projected Nuclear Regulatory Commission regulations. 16 figures, 4 tables

Alternate strategy for commercial high-level radioactive-waste management

A current strategy of geologic disposal of immobilized commercial, high-level, nuclear wastes provides long-term storage (hundreds of thousands of years) for a wide spectrum of wastes from the Purex process which would be immobilized in a borosilicate glass. When implaced in a repository, the temperature increases and peaks within the geologic formations housing the waste repository during the first several hundred years after burial and then declines towards the initial temperature. During this thermal and radiolysis pulse period, the geologic formation and waste packages could be significantly perturbed unless the effects are controlled by some engineered approach. Many of the proposed solutions introduce new economic penalties and/or have serious impacts on how the volume of waste must be handled in production, transportation and final interment in the repository. It is noted that the majority of the thermal energy (has high as 98% after 30 years) in commercial waste aged between 3 and 150 years is due to only two radioactive isotopes, /sup 90/Sr and /sup 137/Cs and their decay chains, which constitute < 10 wt. % of the total elements in HLW. Thus removal of cesium and strontium from all the other HLW components greatly reduces the geologic/waste package perturbations caused by the thermal/radiolysis pulse